Results 91 to 100 of about 2,055 (188)

Comparing and combining xevinapant with ATR and PARP inhibition for the radiosensitization of HPV-negative HNSCC cells. [PDF]

Sci Rep
Roehrle J, Perugachi-Heinsohn A, Gatzemeier F, Christiansen S, Petersen C, Rothkamm K, Betz C, Kriegs M, Zech HB, Rieckmann T.   +9 more
europepmc   +1 more source

Enantioselective synthesis of spiro[indoline-3,1'-pyrazolo[1,2-<i>b</i>]phthalazine] derivatives <i>via</i> an organocatalytic three-component cascade reaction. [PDF]

RSC Adv
Song L, Sun Y, An R, Wang L, Jin Y.
europepmc   +1 more source

Pulmonary Embolism Associated with Olaparib in <i>BRCA2</i>-Mutated Prostate Cancer: A Case Report. [PDF]

Curr Oncol
Ishii S, Maekawa S, Amano F, Kikuchi D, Ikarashi D, Kato R, Kanehira M, Takata R, Sugimura J, Obara W.   +9 more
europepmc   +1 more source

Phthalazines. XIII. Reaction of 1-Substituted Phthalazine 3-Oxides with Acetylenic Dienophiles

YAKUGAKU ZASSHI, 1981
ETSUO OISHI, HIROKO YAMAMOTO, EISAKU HAYASHI   +2 more
openaire   +2 more sources

A phase 1 study of ASTX727 plus talazoparib in patients with triple-negative or hormone resistant/HER2-negative metastatic breast cancer. [PDF]

Cancer
Miller KD, Thomas A, Althouse S, Zang Y, Conder E, Burgos R, Schneider BP, Ballinger T, Douglas E, Ansley K, Jang HJ, Chung W, Issa JP, Nephew KP, Rassool FV.   +14 more
europepmc   +1 more source

Over Two Years of Sustained Remission With Olaparib Monotherapy in Stage IV Non-Small Cell Lung Cancer With ATM Mutation: A Case Report. [PDF]

Cancer Rep (Hoboken)
Tang Z, Bi R, Idriss M, Wang Q, Wang Q, Ban-Hoefen M.   +5 more
europepmc   +1 more source

Differential sensitivity of MCPH1- and BRCA2-deficient cancer cells to PARP-1 inhibition. [PDF]

PLoS One
Chapman IG, Wu X, Veuger S, Jowsey PA.
europepmc   +1 more source

The TALAPRO-3 study design: a plain language summary. [PDF]

Future Oncol
Agarwal N, Saad F, Azad AA, Mateo J, Matsubara N, Shore ND, Chakrabarti J, Chen HC, Lanzalone S, Niyazov A, Fizazi K.   +10 more
europepmc   +1 more source

Comparative analysis of molecular targeted radiosensitizers in 2D and 3D cancer cell line models. [PDF]

Acta Oncol
Ramirez Parra M, Dietrich A, Pfeifer M, Willers H, Krause M, Borgeaud N.   +5 more
europepmc   +1 more source

Altered Estrogen Receptor Signaling Pathway in BRCA2-Deficient Estrogen Receptor-Positive/HER2-Negative Breast Cancer. [PDF]

Cancer Rep (Hoboken)
Kawasaki K, Masuyama M, Shimoda M, Seto I, Mishima C, Sota Y, Abe K, Masunaga N, Tsukabe M, Yoshinami T, Miyake T, Tanei T, Shimazu K.   +12 more
europepmc   +1 more source